Daily Morning Note – 30 May 2019
WEEKLY MARKET OUTLOOK WEBINAR
Register HERE for MONDAY’s 11.15am webinar.
Archived webinars available.
YOUR PHILLIP SUMMARY
Stocks in Asia were set to slip on Wednesday following a overnight session on Wall Street that saw the Dow Jones Industrial Average dropping more than 200 points. Futures pointed to a lower open for the Nikkei 225 in Japan.
Trade war tensions rise as the biggest Chinese newspaper, the People’s Daily, explicitly warned the U.S. on Wednesday that China would cut off rare earth minerals as a countermeasure in the escalated trade battle, using an expression the publication has only used twice in history, both of which involved full-on wars. In addition, the US released a list of countries – including Malaysia and Singapore – that it would scrutinise for unfair currency practices.
Current Sentiment: BULLISH
Starbucks has been a raging bull since the mid of 2018. Based on several technical factors, the stock will most likely continue its bullish move.
Clearbridge Health Limited – Ramping up
Recommendation: BUY (Maintained), Last Close Price: S$0.15
Target Price: S$0.28 (unchanged), Analyst: Phillip Research Team
– 1Q19 revenue/PATMI made up 7.4%/0.3% of our full-year estimates.
– Healthcare system revenue surged 892% YoY to S$1.3mn.
– Medical clinics and centres revenue grew 267% YoY to S$0.9mn.
– We expect higher revenue contribution from the new acquisitions and business
expansions to kick in from 2Q19 onwards to reach our FY19e earnings
– Maintain Buy with an unchanged TP of S$0.28.
Astrea IV – ASTLC 4 MTGE
Recommendation: Not Rated, Analyst: Natalie Ong
– Fitch upgraded Class A-1 bonds from Asf to A+sf, and affirmed class A-2 and
class B bond’s Asf and BBBsf ratings.
– NAV and Undrawn Capital Commitments as at 31 March 2019 stand at
US$929mn and US$127mn respectively.
– Available cash flow on for the period ended 14 December 2018 totalled
US$148m; used to satisfy operating expenses, interest payments to
bondholders, payments to Reserve Accounts and for Liquidity and Capital Call
– Residual cash of US$91.1mn paid out to Sponsor (equity holder) makes up
14.5% of total equity.
Hyflux is in talks with seven different parties for a potential cash infusion, and plans to enter into a binding term sheet with one of them by mid-June. The distressed water cleaning firm will meet stakeholders and draw up terms of a restructuring scheme by the end of June, and aims to apply for leave to convene scheme meetings for creditors in July.
Mainboard-Listed United Food Holdings saw loss attributable to owners widen to 27.6 million yuan (S$5.5 million) for the three months ended March 31 from a loss of 13.44 million yuan in the year-ago period, the firm said in its results release on Wednesday. This was despite revenue rising to 10 million yuan, more than 3.5 times the 2.82 million yuan figure in the year-ago period. The revenue was mainly from the group’s trading segment. The firm is also a producer and supplier of soya bean products and animal feed in China.
Mainboard-listed Valuetronics Holdings’ net profit declined 2.6 per cent to HK$199.5 million (S$35.1 million) for the year ended March 31, from HK$204.7 million a year ago, amid mixed performance from its two business segments.
Myanmar-Focused Yoma Strategic Holdings on Wednesday posted a fourth-quarter net profit of US$25.7 million, from US$432,000 a year ago, mainly due to net fair value gains from investment properties. This was partially offset by a rise in financing costs from higher borrowings and the rising interest rate environment, the group said in a regulatory filing.
Source: SGX Masnet, The Business Times, Bloomberg, Channel NewsAsia, Reuters, PSR
Clients of Phillip Securities can keep updated with Country Strategy and Singapore Sector Reports by logging into: www.poems.com.sg > STOCKS > Research
|The information contained in this email and/or its attachment(s) is provided to you for information only and is not intended to or nor will it create/induce the creation of any binding legal relations. The information or opinions provided in this email do not constitute an investment advice, an offer or solicitation to subscribe for, purchase or sell the e investment product(s) mentioned herein. It does not have any regard to your specific investment objectives, financial situation and any of your particular needs. Accordingly, no warranty whatsoever is given and no liability whatsoever is accepted for any loss arising whether directly or indirectly as a result of this information. Investments are subject to investment risks including possible loss of the principal amount invested. The value of the product and the income from them may fall as well as rise. You may wish to seek advice from an independent financial adviser before making a commitment to purchase or investing in the investment product(s) mentioned herein. In the event that you choose not to do so, you should consider whether the investment product(s) mentioned herein is suitable for you. PhillipCapital and any of its members will not, in any event, be liable to you for any direct/indirect or any other damages of any kind arising from or in connection with your reliance on any information in and/or materials attached to this email. The information and/or materials provided “as is” without warranty of any kind, either express or implied. In particular, no warranty regarding accuracy or fitness for a purpose is given in connection with such information and materials.|
|This e-mail and its attachment(s) may contain privileged or confidential information, which is intended only for the use of the recipient(s) named above. If you have received this message in error, please notify the sender immediately and delete all copies of it. If you are not the intended recipient, you must not read, use, copy, store, disseminate and/or disclose to any person this email and any of its attachment(s). PhillipCapital and its members will not accept legal responsibility for the contents of this message. Thank you for your cooperation.|